Presentation on the effect of the administration of sufentanil sublingual tablet on reducing post-operative recovery time and opioid use in plastic surgery at the annual miami cosmetic surgery event

Hayward, calif., aug. 26, 2021 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced an upcoming presentation on the effects of administering sufentanil sublingual tablet 30 mcg (sst) at miami cosmetic surgery held at the miami beach convention center in miami beach, florida from august 25-27, 2021.
ACRX Ratings Summary
ACRX Quant Ranking